SAPHIRe: Securing the Adoption of Personalised Medicine in Regions
The Department of Economy, Science and Innovation of the Flemish government coordinates the Horizon 2020 Coordination and Support Action SAPHIRe, which started on 1 December 2018. The aim of the project is to secure the adoption of personalised medicine in all European regions, including sparsely populated and remote regions and regions with different innovation capacities. The project is meant as a support to the agenda of the International Consortium of Personalised Medicine (ICPerMed), formally established in November 2016 at the initiative of the European Commission.
To support regions in Europe to embrace personalised medicine in regional healthcare systems SAPHIRe identifies and addresses specific regional gaps and barriers. For these purposes a mapping effort was initiated that also focusses on regional policies with respect to personalised medicine and strengths and best practices.
Furthermore, SAPHIRe wants to create a network of regions and their ecosystems and stakeholders across the entire value chains. This will be done by site visits to regions and the organisation of interactive workshops.
Pilot projects in and between regions may provide the much-needed evidence for the adoption of personalised medicine. The information gathered by SAPHIRe will allow to extract region-specific recommendations on policy, funding and investments needs and interregional (cross-border) collaboration projects may be developed. Ultimately SAPHIRe aims to develop a modular roadmap for the implementation of personalised medicine in regions. Pilot projects that realise this interregional added value, can attract external (European public or private) funding, in addition to their own regional funding.
The activities of SAPHIRe are complementary to the smart specialisation partnership on personalised medicine – S3P4PM, which is also coordinated by the Department of Economy, Science and Innovation.